Key Features

  • Understand current approaches to treating and managing cardiovascular patients for long-term health, for complex problems, and for unusual cardiac events.
  • Benefit from the substantial experience of Elliott M. Antman, MD, Marc S. Sabatine, MD, and a host of other respected authorities, who provide practical, evidence-based rationales for all of today's clinical therapies.
  • Expand your knowledge beyond pharmacologic interventions with complete coverage of the most effective interventional and device therapies being used today.
  • Easily reference Braunwald's Heart Disease, 9th Edition for further information on topics of interest.

Table of Contents

PART I DECISION MAKING AND THERAPEUTIC STRATEGIES IN CARDIOVASCULAR

MEDICINE

Chapter 1 Tools for Assessment of Cardiovascular Tests and Therapies

Chapter 2 New Drug Development

Chapter 3 Device Development for Cardiovascular Therapeutics: Concepts and Regulatory Implications

Chapter 4 Pharmacogenetics

Chapter 5 Systems of Health Care

Chapter 6 Global Cardiovascular Therapy

PART II ISCHEMIC HEART DISEASE

Chapter 7 Pharmacologic Options for Treatment of Ischemic Disease

Chapter 8 Stable Ischemic Heart Disease/Chronic Stable Angina

Chapter 9 Non–ST-Segment Elevation Acute Coronary Syndromes

Chapter 10 ST-Segment Elevation Myocardial Infarction

Chapter 11 Advances in Coronary Revascularization

PART III HEART FAILURE

Chapter 12 Pharmacologic Management of Heart Failure in the Ambulatory Setting

Chapter 13 Implantable Devices for the Management of Heart Failure

Chapter 14 Strategies for Management of Acute Decompensated Heart Failure

Chapter 15 Cardiac Transplantation and Circulatory Support Devices

Chapter 16 Regenerative Therapy for Heart Failure

Chapter 17 Hypertrophic, Restrictive, and Infiltrative Cardiomyopathies

PART IV ARRHYTHMIAS AND CONDUCTION DISTURBANCES

Chapter 18 Clinical Pharmacology of Antiarrhythmic Drugs

Chapter 19 Pharmacologic Management of Supraventricular Tachycardias

Chapter 20 Atrial Fibrillation

Chapter 21 Nonpharmacologic Treatment of Tachyarrhythmias

Chapter 22 Role of Implantable Cardioverter-Defibrillators in Primary and Secondary Prevention of Sudden Cardiac Death

Chapter 23 Treatment of Ventricular Tachycardia and Cardiac Arrest

PART V DYSLIPOPROTEINEMIAS AND ATHEROSCLEROSIS

Chapter 24 Drugs for Elevated Low-Density Lipoprotein

Details

No. of pages:
832
Language:
English
Copyright:
© 2013
Published:
Imprint:
Saunders
Electronic ISBN:
9781455737376
Electronic ISBN:
9780323245111
Print ISBN:
9781455701018